全文获取类型
收费全文 | 4356篇 |
免费 | 372篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 15篇 |
儿科学 | 139篇 |
妇产科学 | 152篇 |
基础医学 | 590篇 |
口腔科学 | 52篇 |
临床医学 | 602篇 |
内科学 | 765篇 |
皮肤病学 | 73篇 |
神经病学 | 420篇 |
特种医学 | 110篇 |
外科学 | 361篇 |
综合类 | 55篇 |
一般理论 | 4篇 |
预防医学 | 634篇 |
眼科学 | 154篇 |
药学 | 282篇 |
中国医学 | 6篇 |
肿瘤学 | 326篇 |
出版年
2023年 | 61篇 |
2022年 | 91篇 |
2021年 | 163篇 |
2020年 | 103篇 |
2019年 | 176篇 |
2018年 | 164篇 |
2017年 | 109篇 |
2016年 | 119篇 |
2015年 | 135篇 |
2014年 | 162篇 |
2013年 | 227篇 |
2012年 | 350篇 |
2011年 | 319篇 |
2010年 | 176篇 |
2009年 | 166篇 |
2008年 | 233篇 |
2007年 | 241篇 |
2006年 | 248篇 |
2005年 | 239篇 |
2004年 | 242篇 |
2003年 | 226篇 |
2002年 | 218篇 |
2001年 | 34篇 |
2000年 | 26篇 |
1999年 | 26篇 |
1998年 | 40篇 |
1997年 | 36篇 |
1996年 | 34篇 |
1995年 | 29篇 |
1994年 | 29篇 |
1993年 | 24篇 |
1992年 | 19篇 |
1991年 | 14篇 |
1990年 | 9篇 |
1989年 | 15篇 |
1988年 | 13篇 |
1987年 | 6篇 |
1986年 | 15篇 |
1985年 | 6篇 |
1984年 | 18篇 |
1983年 | 17篇 |
1982年 | 15篇 |
1981年 | 16篇 |
1980年 | 15篇 |
1978年 | 12篇 |
1977年 | 8篇 |
1976年 | 11篇 |
1972年 | 7篇 |
1970年 | 7篇 |
1968年 | 5篇 |
排序方式: 共有4740条查询结果,搜索用时 0 毫秒
91.
92.
93.
94.
Eric Röhner Paula Hoff Timo Gaber Annemarie Lang Pauline Vörös Frank Buttgereit 《Journal of investigative surgery》2015,28(1):1-7
Purpose/Aim of the study: Chlorhexidine and polyhexanide are frequently used antiseptics in clinical practice and have a broad antimicrobial range. Both antiseptics are helpful medical agents for septic wound treatment with a high potential for defeating joint infections. Their effect on human osteoblasts has, so far, not been sufficiently evaluated. The aim of this study was to investigate the activating potential of polyhexanide and chlorhexidine on inflammatory cytokines/chemokines in human osteoblasts in vitro. Materials and Methods: Human osteoblasts were isolated and cultivated in vitro and then treated separately with 0.1% and 2% chlorhexidine and 0.04% polyhexanide as commonly applied concentrations in clinical practice. Detection of cell structure and cell morphology was performed by light microscopic inspection. Cytokine and chemokine secretion was determined by using a multiplex suspension array. Results: Cell shrinking, defective cell membrane, and the loss of cell adhesion indicated cell damage of human osteoblasts after treatment with both antiseptics was evaluated by using light microscopy. Polyhexanide, but not chlorhexidine, caused human osteoblasts to secrete various interleukins (1β, 6, and 7), interferon γ, tumor necrosis factor α, vascular endothelial growth factor, eotaxin, fibroblast growth factor basic, and granulocyte macrophage colony-stimulating factor as quantified by multiplex suspension array. Conclusions: Both antiseptics induced morphological cell damage at an optimum exposure between 1 and 10 min. But only polyhexanide mediated a pronounced secretion of inflammatory cytokines and chemokines in human osteoblasts. Therefore, we recommend a preferred usage of chlorhexidine in septic surgery to avoid the induction of an inflammatory reaction. 相似文献
95.
96.
Marie Jos Kersten Julia Driessen Jose M. Zijlstra Wouter J. Plattel Franck Morschhauser Pieternella J. Lugtenburg Pauline Brice Martin Hutchings Thomas Gastinne Roberto Liu Coreline N. Burggraaff Marcel Nijland Sanne H. Tonino Anne I.J. Arens Roelf Valkema Harm van Tinteren Marta Lopez-Yurda Arjan Diepstra Daphne De Jong Anton Hagenbeek 《Haematologica》2021,106(4):1129
Achieving a metabolic complete response (mCR) before high-dose chemotherapy (HDC) and autologous peripheral blood stem cell transplant (auto-PBSCT) predicts progression-free survival (PFS) in relapsed/refractory classical Hodgkin lymphoma (R/R cHL). We added brentuximab vedotin (BV) to DHAP (dexamethasone, high-dose cytarabine, cisplatin) to improve the mCR rate. In a phase I dose-escalation part of the study in 12 patients, we showed that BV-DHAP is feasible. This phase II study included 55 R/R cHL patients (23 primary refractory). Treatment consisted of three 21-day cycles of BV 1.8 mg/kg on day 1, and DHAP (dexamethasone 40 mg days 1-4, cisplatin 100 mg/m² day 1 and cytarabine 2x2 g/m² day 2). Patients with a metabolic partial response (mPR) or mCR proceeded to HDC/auto-PBSCT. Based on independent central [18F]fluorodeoxyglucose (FDG) - positron emission tomography (PET) - computed tomography (CT) scan review, 42 of 52 evaluable patients (81% [95%CI: 67-90]) achieved an mCR before HDC/auto-PBSCT, five had an mPR and five had progressive disease (3 were not evaluable). After HDC/auto-PBSCT, four patients with an mPR converted to an mCR. Two-year PFS was 74% [95%CI: 63-86] and overall survival 95% [95%CI: 90-100]. Toxicity was manageable and mainly consisted of grade 3/4 hematologic toxicity, fever, nephrotoxicity, ototoxicity (grade 1/2), and transiently elevated liver enzymes during BV-DHAP. Eighteen patients developed new onset peripheral neuropathy (maximum grade 1/2); all recovered. In conclusion, BV-DHAP is a very effective salvage regimen in R/R cHL patients, but patients should be monitored closely for toxicity. (clinicaltrials.gov identifier: ). NCT02280993相似文献
97.
van Helden PM van den Berg HM Gouw SC Kaijen PH Zuurveld MG Mauser-Bunschoten EP Aalberse RC Vidarsson G Voorberg J 《British journal of haematology》2008,142(4):644-652
The eradication of inhibitory antibodies in patients with haemophilia A can be accomplished by frequent administration of high or intermediate doses of factor VIII (FVIII), so-called immune tolerance induction (ITI). This study monitored the distribution of IgG subclasses of anti-FVIII antibodies during ITI. FVIII-specific antibodies of subclass IgG1 were detected in all inhibitor patients tested, anti-FVIII IgG4 in 16, IgG2 in 10 and IgG3 in one of 20 patients analysed. Levels of anti-FVIII IgG1 and IgG4 correlated well with inhibitor titres as measured by Bethesda assay. In low-titre inhibitor patients, anti-FVIII antibodies consisted primarily of subclass IgG1 whereas, anti-FVIII antibodies of subclass IgG4 were more prominent in patients with high titre inhibitors who needed prolonged treatment or who failed ITI. Longitudinal analysis of 14 patients undergoing ITI revealed that the relative contribution of IgG subclasses was constant for most of the patients analysed. In two patients, the relative contribution of IgG4 increased during ITI. Overall, our findings document the distribution and dynamics of anti-FVIII IgG subclasses during ITI. Future studies will need to address whether monitoring the relative contribution of anti-FVIII subclasses IgG1 and IgG4 may be useful for the identification of patients who are at risk of failing ITI. 相似文献
98.
99.
Anne Pauline Schroeder MD PhD Lars Lyhne Knudsen MD Steen E. Husted MD DMSc Lars Knudsen MD PhD Jørgen Ingerslev MD DMSc 《Journal of thrombosis and thrombolysis》2001,12(2):157-163
In order to assess the applicability of a bedside coagulometer for measurement of b-APTT, serial blood samples were obtained from 20 patients receiving intravenous heparin treatment following PTCA, and from 5 healthy volunteers. B-APTT was analysed bedside on the Hemochron® coagulometer; p-APTT and p-heparin, measured asfactor anti-Xa activity, were analysed ex-vivo in the laboratory. B-APTT values, determined by the Hemochron coagulometer, were closely correlated to p-heparin (r=0.83, p<0.001, SD=52 seconds (sec), n=89), and duplicate determinations of b-APTT on the Hemochron coagulometer showed an acceptable repeatability. However, an APTT ratio of 1.5–2.5 was not related to a therapeutic p-heparin level, neither as measured by the Hemochron device nor in the laboratory.
Abstract. Background: When administering intravenous heparin during angioplasty procedures, a quick and reliable method for safe and effective monitoring of anticoagulation is necessary.
Objective: To assess the applicability of a bedside coagulometer, measuring the activated partial thromboplastin time (APTT) in patients receiving intravenous heparin treatment after percutaneous transluminal coronary angioplasty (PTCA).
Methods: In patients with stable angina pectoris, receiving intravenous heparin treatment following PTCA, serial blood samples were obtained by venipuncture and from the arterial sheath for analysis of whole blood APTT (b-APTT), and plasma heparin concentration (p-heparin). Additionally, in healthy volunteers blood samples were obtained after a single bolus injection of heparin. B-APTT was analysed bedside on the Hemochron® coagulometer; p-APTT and p-heparin, measured as factor anti-Xa activity, were analysed ex-vivo in the laboratory using conventional analytical methods.
Results: In 20 patients a total of 94 venous and 69 arterial blood samples were analysed, and in five healthy volunteers analyses were performed in 20 venous blood samples. B-APTT values, determined by the Hemochron coagulometer, were closely correlated to p-heparin (r=0.83, p<0.001, SD=52 seconds (sec), n=89). An APTT ratio of 1.5–2.5 was not related to a therapeutic p-heparin level, however, neither when using APTT assessed by the Hemochron device nor APTT measured in the laboratory. Duplicate determinations of b-APTT on the Hemochron coagulometer showed an acceptable repeatability; the mean difference between duplicate measurements was 4[emsp4 ] sec (coefficient of variation (c.v.)=6%, p<0.05, n=163).
Conclusions: In patients receiving intravenous heparin after PTCA treatment, b-APTT values measured by the Hemochron method showed an acceptable repeatability and were significantly correlated to p-heparin. 相似文献
100.
Sustained increase in the sharing of needles and syringes among drug users in England and Wales 总被引:2,自引:0,他引:2